Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response.
Primary empathy deficits in frontotemporal dementia.
Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study.
TIGIT is a key inhibitory checkpoint receptor in lymphoma.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TIGIT is a key inhibitory checkpoint receptor in lymphoma.
TIGIT is a key inhibitory checkpoint receptor in lymphoma. J Immunother Cancer. 2023 06; 11(6).
View in:
PubMed
subject areas
Animals
Humans
Lymphoma, Large B-Cell, Diffuse
Mice
Programmed Cell Death 1 Receptor
Receptors, Immunologic
authors with profiles
Girish Venkataraman
Justin Kline